FGF23 induces left ventricular hypertrophy

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369 · see citing works

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318 · see citing works

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · see citing works

Prevalence of Chronic Kidney Disease in the United States

Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · see citing works

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works

A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy

Molkentin, J. D., Lu, J., Antos, C. L., Markham, B. E., Richardson, J. A., Robbins, J. M., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566 · see citing works

Fibroblast growth factors.

Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 1,985 · see citing works

Cellular signaling by fibroblast growth factor receptors

Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,923 · see citing works

Receptor Specificity of the Fibroblast Growth Factor Family

Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871 · see citing works

Regulation of cardiac hypertrophy by intracellular signalling pathways

Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,856 · see citing works

Klotho converts canonical FGF receptor into a specific receptor for FGF23

Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,846 · see citing works

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh‐Hain, J. A., Tamez, H. E., Shah, A., Smith, K. T., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,729 · see citing works

Cardiac Hypertrophy: The Good, the Bad, and the Ugly

Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,458 · see citing works

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.101545198 · Cited by 1,391 · see citing works

Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K., Baum, M., Schiavi, S., Hu, M.-C., Moe, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,356 · see citing works

NFAT Signaling

Crabtree, G. R., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00699-2 · Cited by 1,323 · see citing works

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Martin, C. J., Murray, D. C., & Barré, P. E. (1995) · Kidney International · doi:10.1038/ki.1995.22 · Cited by 1,294 · see citing works

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Isakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, WAHL, P. W., Vargas, G. S., Gutiérrez, O. M., Scialla, J. J., Xie, H., Appleby, D. H., Nessel, L. C., Bellovich, K. A., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,271 · see citing works

Receptor Specificity of the Fibroblast Growth Factor Family

Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601252200 · Cited by 1,164 · see citing works

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Amado, L. C., SALIARIS, A. P., Schuleri, K. H., John, M. S., Xie, J.-S., Cattaneo, S. M., Durand, D. J., Fitton, T. P., Kuang, J. Q., Stewart, G. C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504388102 · Cited by 1,072 · see citing works

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,023 · see citing works

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

Faul, C., Donnelly, M., Merscher, S., Chang, Y. H., Franz, S., Delfgaauw, J., Chang, J., Choi, H. Y., Campbell, K. N., Kim, K., et al. (2008) · Nature Medicine · doi:10.1038/nm.1857 · Cited by 993 · see citing works

The parathyroid is a target organ for FGF23 in rats

Ben‐Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R. M., Kuro‐o, M., Mohammadi, M., Sirkis, R., Naveh‐Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951 · see citing works

Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease

Hu, M. C., Shi, M., Zhang, J., Quiñones, H., Griffith, C. S., Kuro‐o, M., & Moe, O. W. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121311 · Cited by 933 · see citing works

Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease

Gutiérrez, O. M., Isakova, T., Rhee, E. P., Shah, A., Holmes, J., Collerone, G., Diaeresis]ppner, H. J., & Wolf, M. S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 920 · see citing works

Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.

Bader, D. M., Masaki, Τ., & Fischman, D. A. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.95.3.763 · Cited by 919 · see citing works

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Jonsson, K. B., Zahradnik, R. J., Larsson, T. E., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 904 · see citing works

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K. A., Smith, K. T., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E. E., Christenson, R. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 840 · see citing works

The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

Bueno, O. F., Windt, L. J. D., Tymitz, K. M., Witt, S. A., Kimball, T. R., Klevitsky, R., Hewett, T. E., Jones, S. P., Lefer, D. J., Peng, C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774 · see citing works

The Chronic Renal Insufficiency Cohort (CRIC) Study

Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Čižman, B., Daugirdas, J. T., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 660 · see citing works

The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

Shioi, T., Kang, P., Douglas, P., Hampe, J., Yballe, C., Lawitts, J., Cantley, L., & Izumo, S. (2000) · EMBO Journal · doi:10.1093/emboj/19.11.2537 · Cited by 646 · see citing works

Protein kinase cascades in the regulation of cardiac hypertrophy

Dorn, G. W., & Force, T. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24178 · Cited by 637 · see citing works

Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction

Jaye, M., Schlessinger, J., & Dionne, C. A. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90136-y · Cited by 617 · see citing works

Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members

Goetz, R., Beenken, A., Ibrahimi, O., Kalinina, J., Olsen, S., Eliseenkova, A. V., Xu, C.-F., Neubert, T., Zhang, F.-M., Linhardt, R., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02249-06 · Cited by 544 · see citing works

Myosin isoenzyme redistribution in chronic heart overload

Lompré, A., Schwartz, K., d’Albis, A., Lacombe, G., Thiem, N. V., & Bernard Swynghedauw, A. (1979) · Nature · doi:10.1038/282105a0 · Cited by 523 · see citing works

“Stress-Responsive” Mitogen-Activated Protein Kinases (c-Jun N-Terminal Kinases and p38 Mitogen-Activated Protein Kinases) in the Myocardium

Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 519 · see citing works

Calcineurin?NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

Molkentin, J. D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.021 · Cited by 498 · see citing works

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

Muslin, A. J. (2008) · Clinical Science · doi:10.1042/cs20070430 · Cited by 496 · see citing works

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain

Mohammadi, M., Froum, S., Hamby, J. M., Schroeder, M. C., Panek, R. L., Lu, G. H., Eliseenkova, A. V., Green, D., Schlessinger, J., & Hubbard, S. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.20.5896 · Cited by 484 · see citing works

Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo

Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W. J., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477 · see citing works

Regulation of MAPKs by growth factors and receptor tyrosine kinases

Katz, M., Amit, I., & Yarden, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.01.002 · Cited by 468 · see citing works

Alterations of Left Ventricular Hypertrophy in and Survival of Patients Receiving Hemodialysis

London, G. M., Pannier, B., Guérin, A. P., Blacher, J., Marchais, S. J., Darné, B. M., Métivier, F., Adda, H., & Safar, M. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122759 · Cited by 465 · see citing works

The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study

Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457 · see citing works

Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals.

Izumo, S., Lompré, A., Matsuoka, R., Koren, G., Schwartz, K., Nadal‐Ginard, B., & Mahdavi, V. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112908 · Cited by 447 · see citing works

Calcium–calcineurin signaling in the regulation of cardiac hypertrophy

Wilkins, B. J., & Molkentin, J. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.121 · Cited by 439 · see citing works

Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.

Bogoyevitch, M. A., Glennon, P. E., Andersson, M., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J., & Sugden, P. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42228-9 · Cited by 388 · see citing works

Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

Parker, T. G., Packer, S. E., & Schneider, M. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114466 · Cited by 376 · see citing works

Early Control of PTH and FGF23 in Normophosphatemic CKD Patients

de Oliveira, R. C., Cancela, A. L. E., Graciolli, F. G., dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E. F., & Moysés, R. M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05420709 · Cited by 357 · see citing works

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

Jean, G., Terrat, J.-C., Vanel, T., Hurot, J. M., Lorriaux, C., Mayor, B., & Chazot, C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp191 · Cited by 351 · see citing works

Control of Cardiac Gene Expression by Mechanical Stress

Komuro, I., & Yazaki, Y. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.000415 · Cited by 344 · see citing works

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

Mirza, M. A. I., Larsson, A. O., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341 · see citing works

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

Hasegawa, H., Nagano, N., Urakawa, I., Yamazaki, Y., Iijima, K., Fujita, T., Yamashita, T., Fukumoto, S., & Shimada, T. (2010) · Kidney International · doi:10.1038/ki.2010.313 · Cited by 339 · see citing works

Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene.

Molkentin, J. D., Kalvakolanu, D. V., & Markham, B. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4947 · Cited by 309 · see citing works

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

Wolf, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121293 · Cited by 306 · see citing works

Use of tibial length to quantify cardiac hypertrophy: application in the aging rat

Yin, F. C. P., Spurgeon, H. A., Rakusan, K., Weisfeldt, M. L., & Lakatta, E. G. (1982) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1982.243.6.h941 · Cited by 296 · see citing works

Left Ventricular Hypertrophy in the Renal Patient

Middleton, R., Parfrey, P. S., & Foley, R. N. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251079 · Cited by 294 · see citing works

Effect of Hypophosphatemia on Myocardial Performance in Man

O'Connor, L. R., Wheeler, W. S., & Bethune, J. E. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710272971702 · Cited by 292 · see citing works

Prognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis

Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G. L., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122768 · Cited by 292 · see citing works

Differential Expression of the Fibroblast Growth Factor Receptor (FGFR) Multigene Family in Normal Human Adult Tissues

Hughes, S. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500710 · Cited by 283 · see citing works

The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological Potency

Bai, X., Miao, D., Goltzman, D., & Karaplis, A. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210490200 · Cited by 274 · see citing works

Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

Wang, H., Yoshiko, Y., Yamamoto, R., Minamizaki, T., Kozai, K., Tanne, K., Aubin, J. E., & Maeda, N. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080220 · Cited by 263 · see citing works

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

Galitzer, H., Ben‐Dov, I. Z., Silver, J., & Naveh‐Many, T. (2009) · Kidney International · doi:10.1038/ki.2009.464 · Cited by 246 · see citing works

Control of cardiac myosin heavy chain gene expression

Morkin, E. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000915)50:6 · Cited by 239 · see citing works

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling‐Perry, K., Wolf, M. S., Salusky, I. B., & Jüppner, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1603 · Cited by 230 · see citing works

Left Ventricular Hypertrophy in Nondiabetic Predialysis CKD

Paoletti, E., Bellino, D., Cassottana, P., Rolla, D., & Cannella, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.031 · Cited by 218 · see citing works

Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23

Yu, X., Ibrahimi, O. A., Goetz, R. M., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0670 · Cited by 213 · see citing works

Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients

Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G. L., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000117977.14912.91 · Cited by 205 · see citing works

Biological activities of fibroblast growth factor-2 in the adult myocardium

Detillieux, K. A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00708-3 · Cited by 201 · see citing works

Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes.

Bishopric, N. H., Simpson, P. C., & Ordahl, C. P. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113179 · Cited by 200 · see citing works

The Klotho gene family as a regulator of endocrine fibroblast growth factors.

Kurosu, H., & Kuro-o, M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.052 · Cited by 196 · see citing works

Fatty Acid Utilization in the Hypertrophied and Failing Heart: Molecular Regulatory Mechanisms

Barger, P. M., & Kelly, D. P. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199907000-00006 · Cited by 192 · see citing works

Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development

Lincoln, J., Kist, R., Scherer, G., & Yutzey, K. E. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.02.002 · Cited by 187 · see citing works

IMPACT OF RENAL TRANSPLANTATION ON UREMIC CARDIOMYOPATHY

Parfrey, P. S., Harnett, J. D., Foley, R. N., Kent, G. M., Murray, D. C., Barré, P. E., & Guttmann, R. D. (1995) · Transplantation · doi:10.1097/00007890-199511000-00005 · Cited by 173 · see citing works

Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation

Frey, N., Frank, D., Lippl, S., Kühn, C., Kögler, H., Barrientos, T., Rohr, C. M., Will, R. D., Müller, O. J., Weiler-Guettler, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36277 · Cited by 148 · see citing works

The Cytoskeleton and Related Proteins in the Human Failing Heart

Sawa Kostin, D., Hein, S., Arnon, E., Scholz, D., & Schaper, J. (2000) · Heart Failure Reviews · doi:10.1023/a:1009813621103 · Cited by 143 · see citing works

Control of Cardiac Growth and Function by Calcineurin Signaling

Vega, R. B., Bassel‐Duby, R., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300023200 · Cited by 132 · see citing works

The Crystal Structure of Fibroblast Growth Factor (FGF) 19 Reveals Novel Features of the FGF Family and Offers a Structural Basis for Its Unusual Receptor Affinity,

Harmer, N. J., Pellegrini, L., Chirgadze, D., Fernández‐Recio, J., & Blundell, T. L. (2003) · Biochemistry · doi:10.1021/bi035320k · Cited by 124 · see citing works

The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy

Buitrago, M. A. B., Lorenz, K., Maass, A. H., Oberdorf‐Maass, S. U., Keller, U., Schmitteckert, E. M., Ivashchenko, Y., Lohse, M. J., & Engelhardt, S. H. (2005) · Nature Medicine · doi:10.1038/nm1272 · Cited by 116 · see citing works

IMPACT OF RENAL TRANSPLANTATION ON UREMIC CARDIOMYOPATHY

Parfrey, P. S., Harnett, J. D., Foley, R. N., Kent, G. M., Murray, D. C., Barré, P. E., & Guttmann, R. D. (1995) · Transplantation · doi:10.1097/00007890-199511150-00005 · Cited by 114 · see citing works

Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency.

Fuller, T. J., Nichols, W., Brenner, B. J., & Peterson, J. C. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109239 · Cited by 106 · see citing works

Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart

Toraason, M. A., Luken, M. E., Breitenstein, M. J., KRUEGER, J. A., & Biagini, R. E. (1989) · Toxicology · doi:10.1016/0300-483x(89)90216-3 · Cited by 103 · see citing works

Protein Kinase A, Ca2+/Calmodulin-Dependent Kinase II, and Calcineurin Regulate the Intracellular Trafficking of Myopodin between the Z-Disc and the Nucleus of Cardiac Myocytes

Faul, C., Dhume, A., Schecter, A. D., & Mundel, P. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00950-07 · Cited by 86 · see citing works

Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease

Finch, J. L., Tokumoto, M., Nakamura, H. K., Yao, W., Shahnazari, M., Lane, N. E., & Slatopolsky, E. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00552.2009 · Cited by 81 · see citing works

Trophic Effect of Human Pericardial Fluid on Adult Cardiac Myocytes

Corda, S., Mebazaa, A., Gandolfini, M.-P., Fitting, C., Marotte, F., Peynet, J., Charlemagne, D., Cavaillon, J., Payen, D. M., Rappaport, L., et al. (1997) · Circulation Research · doi:10.1161/01.res.81.5.679 · Cited by 80 · see citing works

Cardiovascular Abnormalities in Patients with X-Linked Hypophosphatemia

Nehgme, R., Fahey, J. T., Smith, C. R., & Carpenter, T. O. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4181 · Cited by 77 · see citing works

Fibroblast growth factor 2 isoforms and cardiac hypertrophy

Kardami, E. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.024 · Cited by 71 · see citing works

Stimulus specific changes of energy metabolism in hypertrophied heart

Rimbaud, S., Sanchez, H., Garnier, A., Fortin, D., Bigard, X. A., Veksler, V., & Ventura‐Clapier, R. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.013 · Cited by 54 · see citing works

Promotion of importin α–mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3

Faul, C., Hüttelmaier, S., Oh, J. S., Hachet, V., Singer, R. H., & Mundel, P. H. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411169 · Cited by 50 · see citing works

Cardioprotective effect of calcineurin inhibition in an animal model of renal disease

Marco, G. S. D., Reuter, S., Kentrup, D., Ting, L., Liu, T., Grabner, A., Jacobi, A. M., Pavenstädt, H., Baba, H. A., Tiemann, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq436 · Cited by 39 · see citing works

Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats

Scheinowitz, M., Kotlyar, A., Zimand, S., Ohad, D. G., Leibovitz, I., Bloom, N., Goldberg, I., Nass, D., Engelberg, S., Savion, N., et al. (1998) · Experimental Physiology · doi:10.1113/expphysiol.1998.sp004140 · Cited by 28 · see citing works

Biologists abandon Popper at their peril

(2000) · doi:10.1002/(sici)1521-1878(200002)22:2

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782 · see citing works

The Fibroblast Growth Factor signaling pathway

Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050 · see citing works

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD

Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Tamura, M. K., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,783 · see citing works

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association

Rangaswami, J., Bhalla, V., Blair, J. E., Chang, T. I., Costa, S. P., Lentine, K. L., Lerma, E. V., Mezue, K. N., Molitch, M. E., Müllens, W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000664 · Cited by 1,479 · see citing works

The Osteocyte: An Endocrine Cell … and More

Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042 · see citing works

The Klotho proteins in health and disease

Kuro-o, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0078-3 · Cited by 707 · see citing works

Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schäeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 698 · see citing works

Nutritional Management of Chronic Kidney Disease

Kalantar-Zadeh, K., & Fouque, D. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1700312 · Cited by 636 · see citing works

Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism

Hu, M. C., Shiizaki, K., Kuro-o, M., & Moe, O. W. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183727 · Cited by 587 · see citing works

Cardiovascular disease in dialysis patients

Cozzolino, M. G., Mangano, M., Stucchi, A., Ciceri, P., Conte, F., & Galassi, A. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy174 · Cited by 576 · see citing works

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

Grabner, A., Amaral, A. P., Schramm, K. J., Singh, S., Sloan, A. J., Yanucil, C., Li, J., Shehadeh, L. A., Hare, J. M., David, V., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.002 · Cited by 546 · see citing works

Effects of Phosphate Binders in Moderate CKD

Block, G. A., Wheeler, D. C., Persky, M. S., Kestenbaum, B. R., Ketteler, M., Spiegel, D. M., Allison, M., Asplin, J. R., Smits, G., Hoofnagle, A. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030223 · Cited by 542 · see citing works

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

Haffner, D., Emma, F., Eastwood, D. M., Duplan, M. B., Bacchetta, J., Schnabel, D., Wicart, P., Böckenhauer, D., Santos, F., Levtchenko, E. N., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0152-5 · Cited by 526 · see citing works

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

David, V., Martin, A., Isakova, T., Spaulding, C., Qi, L., Ramirez, V., Zumbrennen‐Bullough, K. B., Sun, C. C., Lin, H. Y.-F., Babitt, J. L., et al. (2015) · Kidney International · doi:10.1038/ki.2015.290 · Cited by 495 · see citing works

The systemic nature of CKD

Zoccali, C., Vanholder, R. C., Massy, Z. A., Ortíz, A., Sarafidis, P. A., Dekker, F. W., Fliser, D., Fouque, D. P., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 464 · see citing works

Fibroblast Growth Factor-23 and Cardiovascular Events in CKD

Scialla, J. J., Xie, H., Rahman, M., Anderson, A. H., Isakova, T., OJO, A. O., Zhang, X., Nessel, L. C., Hamano, T., Grunwald, J. E., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050465 · Cited by 443 · see citing works

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23

Degirolamo, C., Sabbà, C., & Moschetta, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.9 · Cited by 424 · see citing works

FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality

Shalhoub, V., Shatzen, E. M., Ward, S. C., Davis, J., Stevens, J. L., Bi, V., Renshaw, L., Hawkins, N., Wang, W., Chen, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61405 · Cited by 417 · see citing works

Update on fibroblast growth factor 23 in chronic kidney disease

Wolf, M. S. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 392 · see citing works

Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences

Panizo, S., Martínez‐Arias, L., Alonso‐Montes, C., Cannata, P., Martín-Carro, B., Martín, J. L. F., Naves‐Díaz, M., Carrillo‐López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 375 · see citing works

KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)

Isakova, T., Nickolas, T. L., Denburg, M., Yarlagadda, S. G., Weiner, D. E., Gutiérrez, O. M., Bansal, V., Rosas, S. E., Nigwekar, S. U., Yee, J., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.07.019 · Cited by 374 · see citing works

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets

Lim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., & Urquhart, B. L. (2021) · Toxins · doi:10.3390/toxins13020142 · Cited by 381 · see citing works

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

Zoccali, C., Mallamaci, F., Adamczak, M., de Oliveira, R. B., Massy, Z. A., Sarafidis, P. A., Agarwal, R., Mark, P. B., Kotanko, P., Ferro, C. J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad083 · Cited by 385 · see citing works

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease

Singh, S., Grabner, A., Yanucil, C., Schramm, K. J., Czaya, B. A., Krick, S., Czaja, M. J., Bartz, R., Abraham, R., Marco, G. S. D., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.05.019 · Cited by 361 · see citing works

Bone and muscle: Interactions beyond mechanical

Brotto, M. A. P., & Bonewald, L. F. (2015) · Bone · doi:10.1016/j.bone.2015.02.010 · Cited by 347 · see citing works

The Effects of High-Protein Diets on Kidney Health and Longevity

Ko, G.-J., Rhee, C. M., Kalantar-Zadeh, K., & Joshi, S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010028 · Cited by 345 · see citing works

Secondary Osteoporosis

Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 354 · see citing works

Arterial calcification and bone physiology: role of the bone–vascular axis

Thompson, B., & Towler, D. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.36 · Cited by 336 · see citing works

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

Scialla, J. J., Lau, W. L., Reilly, M. P., Isakova, T., Yang, H.-Y. L., Crouthamel, M. H., Chavkin, N. W., Rahman, M., WAHL, P. W., Amaral, A. P., et al. (2013) · Kidney International · doi:10.1038/ki.2013.3 · Cited by 333 · see citing works

Therapeutic management of hypophosphatemic rickets from infancy to adulthood

Linglart, A., Biosse-Duplan, M., Briot, K., Chaussain, C., Esterle, L., Guillaume-Czitrom, S., Kamenicky, P., Nevoux, J., Prié, D., Rothenbuhler, A., et al. (2014) · Endocrine Connections · doi:10.1530/ec-13-0103 · Cited by 331 · see citing works

Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart

Xie, J., Cha, S., An, S.-W., Kuro‐o, M., Birnbaumer, L., & Huang, C.-L. (2012) · Nature Communications · doi:10.1038/ncomms2240 · Cited by 330 · see citing works

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

Ix, J. H., Katz, R., Kestenbaum, B. R., de Boer, I. H., Chonchol, M., Mukamal, K. J., Rifkin, D. E., Siscovick, D. S., Sarnak, M. J., & Shlipak, M. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.040 · Cited by 325 · see citing works

FGF23 regulates renal sodium handling and blood pressure

Andrukhova, O., Slavić, S., Тихоновна, С. А., Zeitz, U., Shalhoub, V., Lanske, B., Pohl, E. E., & Erben, R. G. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303716 · Cited by 321 · see citing works

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

Block, G. A., Bushinsky, D. A., Cheng, S., Cunningham, J., Dehmel, B., Drüeke, T. B., Ketteler, M., Kewalramani, R., Martin, K. J., Moe, S. M., et al. (2017) · JAMA · doi:10.1001/jama.2016.19468 · Cited by 319 · see citing works

Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD

Park, M., Hsu, C., Li, Y., Mishra, R., Keane, M. G., Rosas, S. E., Dries, D. L., Xie, D., Chen, J., He, J., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020145 · Cited by 318 · see citing works

Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho

Yamada, S., & Giachelli, C. M. (2016) · Bone · doi:10.1016/j.bone.2016.11.012 · Cited by 318 · see citing works

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., Correa‐Rotter, R., Drüeke, T. B., Herzog, C. A., London, G. M., Mahaffey, K. W., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013876 · Cited by 305 · see citing works

Chronic Kidney Disease: A Clinical Model of Premature Aging

Stenvinkel, P., & Larsson, T. E. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.051 · Cited by 298 · see citing works

Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models

Su, N. Y., Jin, M. Y., & Chen, L. (2014) · Bone Research · doi:10.1038/boneres.2014.3 · Cited by 291 · see citing works

Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update

Roumeliotis, S. K., Mallamaci, F., & Zoccali, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082359 · Cited by 295 · see citing works

FGF23 and its role in X-linked hypophosphatemia-related morbidity

Beck‐Nielsen, S. S., Zulf Mughal, M., Haffner, D., Nilsson, O., Levtchenko, E. N., Ariceta, G., Collantes, C. D. L., Schnabel, D., Jandhyala, R., & Mäkitie, O. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1014-8 · Cited by 288 · see citing works

Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling

Hu, M. C., Shi, M., Cho, H. J., ADAMS-HUET, B. A., Paek, J., Hill, K., Shelton, J. M., Amaral, A. P., Faul, C., Taniguchi, M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050465 · Cited by 278 · see citing works

FGF23 signaling impairs neutrophil recruitment and host defense during CKD

Rossaint, J., Oehmichen, J., Aken, H. V., Reuter, S., Pavenstädt, H. J., Meersch, M., Unruh, M. L., & Zarbock, A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83470 · Cited by 277 · see citing works

Fibroblast Growth Factor 23 and Inflammation in CKD

Mendoza, J. M., Isakova, T., Ricardo, A. C., Xie, H., Navaneethan, S. D., Anderson, A. H., Bazzano, L., Xie, D., Kretzler, M., Nessel, L. C., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13281211 · Cited by 270 · see citing works

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet

Lau, W. L., Leaf, E. M., Hu, M. C., Takeno, M. M., Kuro‐o, M., Moe, O. W., & Giachelli, C. M. (2012) · Kidney International · doi:10.1038/ki.2012.322 · Cited by 266 · see citing works

Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy

Hu, M. C., Shi, M., Gillings, N., Flores, B., Takahashi, M., Kuro‐o, M., & Moe, O. W. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.034 · Cited by 264 · see citing works

Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate

Xie, J., Yoon, J., An, S.-W., Kuro‐o, M., & Huang, C.-L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040325 · Cited by 263 · see citing works

High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III

Chang, A. R., Lazo, M., Appel, L. J., Gutiérrez, O. M., & Grams, M. E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.073148 · Cited by 262 · see citing works

Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study

Michaëlsson, K., Melhus, H., Lemming, E. W., Wolk, A., & Byberg, L. (2013) · BMJ · doi:10.1136/bmj.f228 · Cited by 260 · see citing works

Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism

Kuro‐o, M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.111 · Cited by 254 · see citing works

The role of phosphate in kidney disease

on behalf of the ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group, Vervloet, M. G., Sezer, S., Massy, Z. A., Johansson, L., Cozzolino, M. G., & Fouque, D. P. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.164 · Cited by 252 · see citing works

Vascular calcification: from pathophysiology to biomarkers

Evrard, S., Delanaye, P., Kamel, S., Cristol, J., Cavalier, E., Arnaud, J., Zaoui, P., Carlier, M.-C., Laville, M., Fouque, D. P., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.034 · Cited by 244 · see citing works

Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment

Lullo, L. D., Gorini, A., Russo, D., Santoboni, A., & Ronco, C. (2015) · Cardiorenal Medicine · doi:10.1159/000435838 · Cited by 235 · see citing works

Interactions Between Muscle Tissues and Bone Metabolism

Kawao, N., & Kaji, H. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25040 · Cited by 231 · see citing works

FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway

Andrukhova, O., Zeitz, U., Goetz, R. M., Mohammadi, M., Lanske, B., & Erben, R. G. (2012) · Bone · doi:10.1016/j.bone.2012.05.015 · Cited by 228 · see citing works

Klotho and Chronic Kidney Disease

Hu, M. C., Kuro‐o, M., & Moe, O. W. (2013) · Contributions to nephrology · doi:10.1159/000346778 · Cited by 227 · see citing works

Genetic insights into the mechanisms of Fgf signalingPreprint

Brewer, J. R., Mazot, P., & Soriano, P. M. (2016) · Genes & Development · doi:10.1101/gad.277137.115 · Cited by 224 · see citing works

Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease

Lü, X., & Hu, M. C. (2016) · Kidney Diseases · doi:10.1159/000452880 · Cited by 220 · see citing works

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Chirinos, J. A., Orlenko, A., Zhao, L., Basso, M., Cvijic, M. E., Li, Z., Spires, T. E., Yarde, M., Wang, Z., Seiffert, D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.069 · Cited by 218 · see citing works

The chronic kidney disease — Mineral bone disorder (CKD-MBD): Advances in pathophysiology

Hruska, K. A., Sugatani, T., Agapova, O. A., & Fang, Y. (2017) · Bone · doi:10.1016/j.bone.2017.01.023 · Cited by 215 · see citing works

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

Babitt, J. L., Eisenga, M. F., Haase, V. H., Kshirsagar, A. V., Levin, A., Locatelli, F., Małyszko, J., Swinkels, D. W., Tarng, D., Cheung, M., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.020 · Cited by 222 · see citing works

Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease

Tonelli, M. A., Karumanchi, S. A., & Thadhani, R. (2016) · Circulation · doi:10.1161/circulationaha.115.018713 · Cited by 214 · see citing works

Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.

Angelin, B., Larsson, T., & Rudling, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.001 · Cited by 210 · see citing works

Cardiovascular disease in chronic kidney disease: untying the Gordian knot

Hajhosseiny, R., Khavandi, K., & Goldsmith, D. J. A. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02954.x · Cited by 207 · see citing works

Therapeutics Targeting FGF Signaling Network in Human Diseases

Katoh, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.10.003 · Cited by 206 · see citing works

New Insights into the Mechanism of Action of Soluble Klotho

Dalton, G. D., Xie, J., An, S.-W., & Huang, C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00323 · Cited by 210 · see citing works

FGF23 Actions on Target Tissues—With and Without Klotho

Richter, B., & Faul, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00189 · Cited by 205 · see citing works

Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure

Dhondup, T., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452725 · Cited by 202 · see citing works

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease

Leifheit‐Nestler, M., Siemer, R. G., Flasbart, K., Richter, B., Kirchhoff, F., Ziegler, W. H., Klintschar, M., Becker, J. U., Erbersdobler, A., Aufricht, C., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv421 · Cited by 200 · see citing works

Coupling fibroblast growth factor 23 production and cleavage

Wolf, M. S., & White, K. E. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000447020.74593.6f · Cited by 198 · see citing works

Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism

Komaba, H., Taniguchi, M., Wada, A., Iseki, K., Tsubakihara, Y., & Fukagawa, M. (2015) · Kidney International · doi:10.1038/ki.2015.72 · Cited by 197 · see citing works

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis

Marthi, A., Donovan, K., Haynes, R., Wheeler, D. C., Baigent, C., Rooney, C. M., Landray, M., Moe, S. M., Yang, J. M., Holland, L., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017121334 · Cited by 194 · see citing works

Cardiorenal syndrome: pathophysiology and potential targets for clinical management

Hatamizadeh, P., Fonarow, G. C., Budoff, M. J., Darabian, S., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.279 · Cited by 195 · see citing works

A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model

Dai, B., David, V., Martin, A., Huang, J., Li, H., Jiao, Y., Gu, W., & Quarles, L. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044161 · Cited by 195 · see citing works

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

Touchberry, C., Green, T. M., Tchikrizov, V., Mannix, J., Mao, T. F., Carney, B. W., Girgis, M., Vincent, R. J., Wetmore, L. A., Dawn, B., et al. (2013) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00596.2012 · Cited by 195 · see citing works

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease

Scialla, J. J., & Wolf, M. S. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.49 · Cited by 194 · see citing works

Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes

Bacchetta, J., Sea, J. L., Chun, R. F., Lisse, T. S., Wesseling‐Perry, K., Gales, B., Adams, J. S., Salusky, I. B., & Hewison, M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1740 · Cited by 190 · see citing works

Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease

Felsenfeld, A. J., Levine, B. S., & Rodriguez, M. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12411 · Cited by 189 · see citing works

Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy

Yang, K., Wang, C., Nie, L., Zhao, X., Gu, J., Guan, X., Wang, S., Xiao, T., Xu, X., He, T., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060543 · Cited by 189 · see citing works

Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency

Jimbo, R., Kawakami-Mori, F., Mu, S., Hirohama, D., Majtan, B., Shimizu, Y., Yatomi, Y., Fukumoto, S., Fujita, T., & Shimosawa, T. (2013) · Kidney International · doi:10.1038/ki.2013.332 · Cited by 189 · see citing works

FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability

Silswal, N., Touchberry, C. D., Daniel, D., McCarthy, D. L., Zhang, S., Andresen, J. J., Stubbs, J. R., & Wacker, M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00264.2014 · Cited by 189 · see citing works

Cardiorenal Syndrome

Lekawanvijit, S., Kompa, A. R., Wang, B. H., Kelly, D. J., & Krum, H. (2012) · Circulation Research · doi:10.1161/circresaha.112.278457 · Cited by 183 · see citing works

Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study , ,

Lutsey, P. L., Alonso, Á., Michos, E. D., Loehr, L. R., Astor, B. C., Coresh, J., & Folsom, A. R. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.085167 · Cited by 181 · see citing works

Klotho in Clinical Nephrology

Neyra, J. A., Hu, M. C., & Moe, O. W. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02840320 · Cited by 184 · see citing works

FGF23 signalling and physiology

Ho, B. B., & Bergwitz, C. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0178 · Cited by 180 · see citing works

Cardiorenal Syndrome

Kumar, U., Wettersten, N. W., & Garimella, P. S. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.04.001 · Cited by 193 · see citing works

Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging

Serna, J., & Bergwitz, C. (2020) · Nutrients · doi:10.3390/nu12103001 · Cited by 190 · see citing works

CKD-Induced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKD–Mineral and Bone Disorder

Fang, Y., Ginsberg, C., Seifert, M. E., Agapova, O. A., Sugatani, T., Register, T. C., Freedman, B. I., Monier‐Faugere, M., Malluche, H. H., & Hruska, K. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080818 · Cited by 173 · see citing works

Renal and Extrarenal Actions of Klotho

Hu, M. C., Kuro‐o, M., & Moe, O. W. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.013 · Cited by 172 · see citing works

FGF23-Klotho signaling axis in the kidney

Erben, R. G., & Andrukhova, O. (2016) · Bone · doi:10.1016/j.bone.2016.09.010 · Cited by 168 · see citing works

Klotho in health and disease

Kuro-o, M. (2012) · Current opinion in nephrology and hypertension · doi:10.1097/mnh.0b013e32835422ad · Cited by 175 · see citing works

Muscle‐bone crosstalk and potential therapies for sarco‐osteoporosis

Li, G., Zhang, L., Wang, D., AIQudsy, L., Jiang, J. X., Xu, H., & Shang, P. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28946 · Cited by 166 · see citing works

Physiological Actions of Fibroblast Growth Factor-23

Erben, R. G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00267 · Cited by 166 · see citing works

Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population

Covic, A. C., Vervloet, M. G., Massy, Z. A., Ureña, P., Goldsmith, D. J. A., Brandenburg, V. M., Mazzaferro, S., Evenepoel, P., Bover, J., Apetrii, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30310-8 · Cited by 164 · see citing works

Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion

Olauson, H., Lindberg, K., Amin, R., Sato, T., Jia, T., Goetz, R. M., Mohammadi, M., Andersson, G., Lanske, B., & Larsson, T. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003975 · Cited by 163 · see citing works

Evolving concepts in the pathogenesis of uraemic cardiomyopathy

Wang, X., & Shapiro, J. I. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0101-8 · Cited by 165 · see citing works

Disordered FGF23 and Mineral Metabolism in Children with CKD

Portale, A. A., Wolf, M. S., Jüppner, H., Messinger, S., Kumar, J., Wesseling‐Perry, K., Schwartz, G. J., Furth, S. L., Warady, B. A., & Salusky, I. B. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05840513 · Cited by 161 · see citing works

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

Block, G. A., Bushinsky, D. A., Cunningham, J., Drüeke, T. B., Ketteler, M., Kewalramani, R., Martin, K. J., Mix, T.-C. H., Moe, S. M., Patel, U. D., et al. (2017) · JAMA · doi:10.1001/jama.2016.19456 · Cited by 161 · see citing works

Identification of a novel FN1–FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour

Lee, J., Jeng, Y., Su, S.-Y., Wu, C., Tsai, K., Lee, C., Lin, C., Carter, J. M., Huang, J., Chen, S., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4465 · Cited by 160 · see citing works

Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events

Go, A. S., Hsu, C., Yang, J., Tan, T. C., Zheng, S., Ordoñez, J. D., & Liu, K. D. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12591117 · Cited by 159 · see citing works

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease

Leifheit‐Nestler, M., Siemer, R. G., Flasbart, K., Richter, B., Kirchhoff, F., Ziegler, W. H., Klintschar, M., Becker, J. U., Erbersdobler, A., Aufricht, C., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv421 · Cited by 200 · see citing works

Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy

Gutiérrez, O. M. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv445 · Cited by 5 · see citing works

SaO027CARDIO-PATHOLOGICAL EFFECTS OF FGF23 IN CKD ARE MEDIATED BY FGFR4

Grabner, A., Amaral, A. P., Singh, S., Schramm, K. J., Sloan, A. J., Kentrup, D., Reuter, S., Pavenstaedt, H., Marco, G. S. D., Wolf, M., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv150.04

FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD

Hidaka, N., Inoue, K., Katô, H., Hoshino, Y., Koga, M., Kinoshita, Y., Takashi, Y., Makita, N., Fukumoto, S., Nangaku, M., et al. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100747 · Cited by 13 · see citing works

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K. A., Smith, K. T., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E. E., Christenson, R. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 840 · see citing works